Activation of SH2 domain-containing protein tyrosine phosphatase and inflammatory expression in psoriasis
Tác giả: Bui Kieu Trang, Nguyen Thi Kim Lien, Nguyen Thi XuanTóm tắt:
Psoriasis is a chronic autoimmune disease characterized by abnormal proliferation and differentiation of keratinocytes and infiltration of inflammatory cells into the site of inflammation. Plaque psoriasis is the most common type of psoriasis, affecting up to 80–90% of psoriasis cases. Among inflammatory cells, myeloid dendritic cells or Langerhans cells are mainly activated cells during the pathogenesis of psoriasis to induce activation and differentiation of naive T cells into T helper cells (Th)1 and Th17 cells. SH2 domain-containing protein tyrosine phosphatase (SHP) is a negative regulator of the phosphorylation of several proteins involved in cellular differentiation, growth and activation. Chronic inflammation promotes tumor progression, which is characterized by the release of carcinogenic antigens, including alpha-fetoprotein (AFP) and cancer antigen 125 (CA125) into blood and urine. They are common tumor markers to serve as predictors of cancer development and survival of cancer patients. To this end, blood samples of 103 psoriasis patients and 46 healthy subjects were collected. This study further hint for investigations on the functional role of SHP1 in regulating activation of immune cells present in psoriasis patients.
- Health-related quality of life and associated factors in children with crohn’s disease at Vietnam National Children’s Hospital
- Hyperuricemia and testosterone deficiency: An underestimated correlation
- Antifungal activity of oxidative damaging agents in combination with metal cations against Trichophyton rubrum isolated from a dermatological patient
- Blockade of interleukin-33 activities by recombinant interleukin-33 Trap Fc protein would be a novel therapeutic strategy in allergic asthma
- Expression of deubiquitinase genes and inflammatory response in myeloid leukemia